Monday, September 07, 2020 10:05:00 AM
Timing trades?
As posted earlier - at the 2019 annual meeting, CW stated face to face that their 3 top programs were worth $6B EACH. Furthermore, an analyst had quoted that for each billion the stock would rise $30 PS. Simple math?
BTW at their last QCC, CW stated that Necuparanib would be tested on Covid 19. Time has passed - what were the results?
They take care of their own. What else is new?
Watch RVNC & ENTA.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
